跳至主要内容
临床试验/NCT06593262
NCT06593262进行中(未招募)不适用

Efficacy of Digital Cognitive Behavioral Therapy for Insomnia (CBT-I) With Artificial Intelligence Chatbot for Youth With Insomnia: An Assessor-blind, Randomized Controlled Trial

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2024年7月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
168
试验地点
1
主要终点
Insomnia Severity Index

研究概览

简要总结

Insomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the efficacy of an app-based CBT-I with AI chatbot in reducing insomnia symptoms among youths, compared to an app-based CBT-I without AI chatbot.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • i. Youth aged 18 to 25 years (as defined by WHO and evidence on AI mental health chatbots only available for individuals aged 18 years and older)
  • ii. Online informed consent of participation in the study should be provided
  • iii. Willing to comply with the requirements of the study protocol
  • iv. The presence of moderate to severe insomnia measured by a score of 15 or above on the Insomnia Severity Index (ISI)
  • v. difficulties initiating, maintaining or nonrestorative sleep over a 1-month period
  • vi. Having access to a smartphone and consistent internet access for their smartphone
  • vii. Accepting the terms of service and privacy policies of the mobile apps used in the study for the delivery of the intervention

排除标准

  • i. A history of any sleep disorder(s) (other than insomnia disorder) such as narcolepsy, obstructive sleep apnea, and restless legs syndrome
  • ii. A history of any mental retardation or neuropsychiatric disorder(s) (other than depression and anxiety disorders as they are the secondary outcomes) such as bipolar disorder, schizophrenia, and substance use disorder
  • iii. Presence of serious suicidality as evidenced by ideation with a plan or an attempt
  • iv. Receiving any pharmacological treatment (including sleep promoting agents)
  • v. Receiving any structured psychotherapy
  • vi. Having shiftwork and trans-meridian travel in the past 3 months and during the intervention

研究组 & 干预措施

app-based digital cognitive behavioral therapy for insomnia with AI chatbot

Experimental

干预措施: app-based digital cognitive behavioral therapy for insomnia with AI chatbot (Behavioral)

app-based digital cognitive behavioral therapy for insomnia without AI chatbot

Active Comparator

干预措施: app-based digital cognitive behavioral therapy for insomnia without AI chatbot (Behavioral)

结局指标

主要结局

Insomnia Severity Index

时间窗: a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

the severity of insomnia symptoms

次要结局

  • sleep onset latency (SOL)(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • wake after sleep onset (WASO)(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • sleep efficiency (SE)(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • Total sleep time (TST)(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Pre-Sleep Arousal Scale(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Cognitive Failures Questionnaire(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • Ford Insomnia Response to Stress Test(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • reduced Horne and Östberg Morningness and Eveningness Questionnaire(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Dysfunctional Beliefs and Attitudes about Sleep Scale(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • Patient Health Questionnaire-9(a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • General Anxiety Disorder-7(a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Sleep Hygiene Index(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Charlotte Attitudes Towards Sleep Scale(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))
  • The Multidimensional Fatigue Inventory(a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tim M. H. Li

Prof.

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验